Your browser doesn't support javascript.
loading
The Efficacy and Safety of Anlotinib in Pediatric Patients With Refractory or Recurrent Solid Tumors.
Lu, Suying; Hong, Ye; Chen, Huimou; Wu, Liuhong; Sun, Feifei; Wang, Juan; Zhu, Jia; Que, Yi; Zhang, Lian; Zhen, Zijun; Sun, Xiaofei; Huang, Junting; Zhang, Yizhuo.
Afiliação
  • Lu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hong Y; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Chen H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wu L; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Sun F; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Wang J; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Que Y; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhen Z; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Sun X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang J; Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Front Pharmacol ; 13: 711704, 2022.
Article em En | MEDLINE | ID: mdl-35431969

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article